Global Transcranial Magnetic Stimulation Treatment Devices Market Growth 2022-2028

Publication Month: Dec 2022 | No. of Pages: 105 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

The global market for Transcranial Magnetic Stimulation Treatment Devices is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Transcranial Magnetic Stimulation Treatment Devices market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Transcranial Magnetic Stimulation Treatment Devices market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Transcranial Magnetic Stimulation Treatment Devices market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Transcranial Magnetic Stimulation Treatment Devices market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Transcranial Magnetic Stimulation Treatment Devices players cover BrainsWay, MAG & More GmbH(Neurocare Group AG), Shenzhen Yingchi Technology, Sebers Medical and Neurosoft, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Transcranial Magnetic Stimulation Treatment Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Transcranial Magnetic Stimulation Treatment Devices market, with both quantitative and qualitative data, to help readers understand how the Transcranial Magnetic Stimulation Treatment Devices market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Transcranial Magnetic Stimulation Treatment Devices market and forecasts the market size by Type (Mono-phasic Magnetic Stimulator and Dual-phasic Magnetic Stimulator,), by Application (Depression, Anxiety Disorder, Obsessive-compulsive Disorder and Smoking Addiction), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Mono-phasic Magnetic Stimulator
Dual-phasic Magnetic Stimulator
Segmentation by application
Depression
Anxiety Disorder
Obsessive-compulsive Disorder
Smoking Addiction
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
BrainsWay
MAG & More GmbH(Neurocare Group AG)
Shenzhen Yingchi Technology
Sebers Medical
Neurosoft
Magstim
MagVenture
NeuroStar
Deymed
Yiruide
Remed
Nexstim
Chapter Introduction
Chapter 1: Scope of Transcranial Magnetic Stimulation Treatment Devices, Research Methodology, etc.
Chapter 2: Executive Summary, global Transcranial Magnetic Stimulation Treatment Devices market size (sales and revenue) and CAGR, Transcranial Magnetic Stimulation Treatment Devices market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transcranial Magnetic Stimulation Treatment Devices sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transcranial Magnetic Stimulation Treatment Devices sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transcranial Magnetic Stimulation Treatment Devices market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including BrainsWay, MAG & More GmbH(Neurocare Group AG), Shenzhen Yingchi Technology, Sebers Medical, Neurosoft, Magstim, MagVenture, NeuroStar and Deymed, etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transcranial Magnetic Stimulation Treatment Devices Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transcranial Magnetic Stimulation Treatment Devices by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transcranial Magnetic Stimulation Treatment Devices by Country/Region, 2017, 2022 & 2028
2.2 Transcranial Magnetic Stimulation Treatment Devices Segment by Type
2.2.1 Mono-phasic Magnetic Stimulator
2.2.2 Dual-phasic Magnetic Stimulator
2.3 Transcranial Magnetic Stimulation Treatment Devices Sales by Type
2.3.1 Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type (2017-2022)
2.3.2 Global Transcranial Magnetic Stimulation Treatment Devices Revenue and Market Share by Type (2017-2022)
2.3.3 Global Transcranial Magnetic Stimulation Treatment Devices Sale Price by Type (2017-2022)
2.4 Transcranial Magnetic Stimulation Treatment Devices Segment by Application
2.4.1 Depression
2.4.2 Anxiety Disorder
2.4.3 Obsessive-compulsive Disorder
2.4.4 Smoking Addiction
2.4.5 Other
2.5 Transcranial Magnetic Stimulation Treatment Devices Sales by Application
2.5.1 Global Transcranial Magnetic Stimulation Treatment Devices Sale Market Share by Application (2017-2022)
2.5.2 Global Transcranial Magnetic Stimulation Treatment Devices Revenue and Market Share by Application (2017-2022)
2.5.3 Global Transcranial Magnetic Stimulation Treatment Devices Sale Price by Application (2017-2022)
3 Global Transcranial Magnetic Stimulation Treatment Devices by Company
3.1 Global Transcranial Magnetic Stimulation Treatment Devices Breakdown Data by Company
3.1.1 Global Transcranial Magnetic Stimulation Treatment Devices Annual Sales by Company (2020-2022)
3.1.2 Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Company (2020-2022)
3.2 Global Transcranial Magnetic Stimulation Treatment Devices Annual Revenue by Company (2020-2022)
3.2.1 Global Transcranial Magnetic Stimulation Treatment Devices Revenue by Company (2020-2022)
3.2.2 Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Company (2020-2022)
3.3 Global Transcranial Magnetic Stimulation Treatment Devices Sale Price by Company
3.4 Key Manufacturers Transcranial Magnetic Stimulation Treatment Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transcranial Magnetic Stimulation Treatment Devices Product Location Distribution
3.4.2 Players Transcranial Magnetic Stimulation Treatment Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transcranial Magnetic Stimulation Treatment Devices by Geographic Region
4.1 World Historic Transcranial Magnetic Stimulation Treatment Devices Market Size by Geographic Region (2017-2022)
4.1.1 Global Transcranial Magnetic Stimulation Treatment Devices Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transcranial Magnetic Stimulation Treatment Devices Annual Revenue by Geographic Region
4.2 World Historic Transcranial Magnetic Stimulation Treatment Devices Market Size by Country/Region (2017-2022)
4.2.1 Global Transcranial Magnetic Stimulation Treatment Devices Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transcranial Magnetic Stimulation Treatment Devices Annual Revenue by Country/Region
4.3 Americas Transcranial Magnetic Stimulation Treatment Devices Sales Growth
4.4 APAC Transcranial Magnetic Stimulation Treatment Devices Sales Growth
4.5 Europe Transcranial Magnetic Stimulation Treatment Devices Sales Growth
4.6 Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales Growth
5 Americas
5.1 Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Country
5.1.1 Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Country (2017-2022)
5.1.2 Americas Transcranial Magnetic Stimulation Treatment Devices Revenue by Country (2017-2022)
5.2 Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Type
5.3 Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Region
6.1.1 APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Region (2017-2022)
6.1.2 APAC Transcranial Magnetic Stimulation Treatment Devices Revenue by Region (2017-2022)
6.2 APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Type
6.3 APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transcranial Magnetic Stimulation Treatment Devices by Country
7.1.1 Europe Transcranial Magnetic Stimulation Treatment Devices Sales by Country (2017-2022)
7.1.2 Europe Transcranial Magnetic Stimulation Treatment Devices Revenue by Country (2017-2022)
7.2 Europe Transcranial Magnetic Stimulation Treatment Devices Sales by Type
7.3 Europe Transcranial Magnetic Stimulation Treatment Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices by Country
8.1.1 Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Revenue by Country (2017-2022)
8.2 Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales by Type
8.3 Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transcranial Magnetic Stimulation Treatment Devices
10.3 Manufacturing Process Analysis of Transcranial Magnetic Stimulation Treatment Devices
10.4 Industry Chain Structure of Transcranial Magnetic Stimulation Treatment Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transcranial Magnetic Stimulation Treatment Devices Distributors
11.3 Transcranial Magnetic Stimulation Treatment Devices Customer
12 World Forecast Review for Transcranial Magnetic Stimulation Treatment Devices by Geographic Region
12.1 Global Transcranial Magnetic Stimulation Treatment Devices Market Size Forecast by Region
12.1.1 Global Transcranial Magnetic Stimulation Treatment Devices Forecast by Region (2023-2028)
12.1.2 Global Transcranial Magnetic Stimulation Treatment Devices Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transcranial Magnetic Stimulation Treatment Devices Forecast by Type
12.7 Global Transcranial Magnetic Stimulation Treatment Devices Forecast by Application
13 Key Players Analysis
13.1 BrainsWay
13.1.1 BrainsWay Company Information
13.1.2 BrainsWay Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.1.3 BrainsWay Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BrainsWay Main Business Overview
13.1.5 BrainsWay Latest Developments
13.2 MAG & More GmbH(Neurocare Group AG)
13.2.1 MAG & More GmbH(Neurocare Group AG) Company Information
13.2.2 MAG & More GmbH(Neurocare Group AG) Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.2.3 MAG & More GmbH(Neurocare Group AG) Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 MAG & More GmbH(Neurocare Group AG) Main Business Overview
13.2.5 MAG & More GmbH(Neurocare Group AG) Latest Developments
13.3 Shenzhen Yingchi Technology
13.3.1 Shenzhen Yingchi Technology Company Information
13.3.2 Shenzhen Yingchi Technology Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.3.3 Shenzhen Yingchi Technology Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Shenzhen Yingchi Technology Main Business Overview
13.3.5 Shenzhen Yingchi Technology Latest Developments
13.4 Sebers Medical
13.4.1 Sebers Medical Company Information
13.4.2 Sebers Medical Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.4.3 Sebers Medical Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sebers Medical Main Business Overview
13.4.5 Sebers Medical Latest Developments
13.5 Neurosoft
13.5.1 Neurosoft Company Information
13.5.2 Neurosoft Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.5.3 Neurosoft Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Neurosoft Main Business Overview
13.5.5 Neurosoft Latest Developments
13.6 Magstim
13.6.1 Magstim Company Information
13.6.2 Magstim Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.6.3 Magstim Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Magstim Main Business Overview
13.6.5 Magstim Latest Developments
13.7 MagVenture
13.7.1 MagVenture Company Information
13.7.2 MagVenture Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.7.3 MagVenture Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 MagVenture Main Business Overview
13.7.5 MagVenture Latest Developments
13.8 NeuroStar
13.8.1 NeuroStar Company Information
13.8.2 NeuroStar Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.8.3 NeuroStar Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 NeuroStar Main Business Overview
13.8.5 NeuroStar Latest Developments
13.9 Deymed
13.9.1 Deymed Company Information
13.9.2 Deymed Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.9.3 Deymed Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Deymed Main Business Overview
13.9.5 Deymed Latest Developments
13.10 Yiruide
13.10.1 Yiruide Company Information
13.10.2 Yiruide Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.10.3 Yiruide Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Yiruide Main Business Overview
13.10.5 Yiruide Latest Developments
13.11 Remed
13.11.1 Remed Company Information
13.11.2 Remed Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.11.3 Remed Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Remed Main Business Overview
13.11.5 Remed Latest Developments
13.12 Nexstim
13.12.1 Nexstim Company Information
13.12.2 Nexstim Transcranial Magnetic Stimulation Treatment Devices Product Offered
13.12.3 Nexstim Transcranial Magnetic Stimulation Treatment Devices Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Nexstim Main Business Overview
13.12.5 Nexstim Latest Developments
14 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Transcranial Magnetic Stimulation Treatment Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transcranial Magnetic Stimulation Treatment Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Mono-phasic Magnetic Stimulator
Table 4. Major Players of Dual-phasic Magnetic Stimulator
Table 5. Global Transcranial Magnetic Stimulation Treatment Devices Sales by Type (2017-2022) & (K Units)
Table 6. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type (2017-2022)
Table 7. Global Transcranial Magnetic Stimulation Treatment Devices Revenue by Type (2017-2022) & ($ million)
Table 8. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Type (2017-2022)
Table 9. Global Transcranial Magnetic Stimulation Treatment Devices Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Transcranial Magnetic Stimulation Treatment Devices Sales by Application (2017-2022) & (K Units)
Table 11. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Application (2017-2022)
Table 12. Global Transcranial Magnetic Stimulation Treatment Devices Revenue by Application (2017-2022)
Table 13. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Application (2017-2022)
Table 14. Global Transcranial Magnetic Stimulation Treatment Devices Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Transcranial Magnetic Stimulation Treatment Devices Sales by Company (2020-2022) & (K Units)
Table 16. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Company (2020-2022)
Table 17. Global Transcranial Magnetic Stimulation Treatment Devices Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Company (2020-2022)
Table 19. Global Transcranial Magnetic Stimulation Treatment Devices Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Transcranial Magnetic Stimulation Treatment Devices Producing Area Distribution and Sales Area
Table 21. Players Transcranial Magnetic Stimulation Treatment Devices Products Offered
Table 22. Transcranial Magnetic Stimulation Treatment Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Transcranial Magnetic Stimulation Treatment Devices Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share Geographic Region (2017-2022)
Table 27. Global Transcranial Magnetic Stimulation Treatment Devices Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Transcranial Magnetic Stimulation Treatment Devices Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country/Region (2017-2022)
Table 31. Global Transcranial Magnetic Stimulation Treatment Devices Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Country (2017-2022) & (K Units)
Table 34. Americas Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country (2017-2022)
Table 35. Americas Transcranial Magnetic Stimulation Treatment Devices Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country (2017-2022)
Table 37. Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Type (2017-2022) & (K Units)
Table 38. Americas Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type (2017-2022)
Table 39. Americas Transcranial Magnetic Stimulation Treatment Devices Sales by Application (2017-2022) & (K Units)
Table 40. Americas Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Application (2017-2022)
Table 41. APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Region (2017-2022) & (K Units)
Table 42. APAC Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Region (2017-2022)
Table 43. APAC Transcranial Magnetic Stimulation Treatment Devices Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Region (2017-2022)
Table 45. APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Type (2017-2022) & (K Units)
Table 46. APAC Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type (2017-2022)
Table 47. APAC Transcranial Magnetic Stimulation Treatment Devices Sales by Application (2017-2022) & (K Units)
Table 48. APAC Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Application (2017-2022)
Table 49. Europe Transcranial Magnetic Stimulation Treatment Devices Sales by Country (2017-2022) & (K Units)
Table 50. Europe Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country (2017-2022)
Table 51. Europe Transcranial Magnetic Stimulation Treatment Devices Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country (2017-2022)
Table 53. Europe Transcranial Magnetic Stimulation Treatment Devices Sales by Type (2017-2022) & (K Units)
Table 54. Europe Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type (2017-2022)
Table 55. Europe Transcranial Magnetic Stimulation Treatment Devices Sales by Application (2017-2022) & (K Units)
Table 56. Europe Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Transcranial Magnetic Stimulation Treatment Devices
Table 66. Key Market Challenges & Risks of Transcranial Magnetic Stimulation Treatment Devices
Table 67. Key Industry Trends of Transcranial Magnetic Stimulation Treatment Devices
Table 68. Transcranial Magnetic Stimulation Treatment Devices Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Transcranial Magnetic Stimulation Treatment Devices Distributors List
Table 71. Transcranial Magnetic Stimulation Treatment Devices Customer List
Table 72. Global Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Forecast by Region
Table 74. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Transcranial Magnetic Stimulation Treatment Devices Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share Forecast by Application (2023-2028)
Table 92. BrainsWay Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. BrainsWay Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 94. BrainsWay Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. BrainsWay Main Business
Table 96. BrainsWay Latest Developments
Table 97. MAG & More GmbH(Neurocare Group AG) Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. MAG & More GmbH(Neurocare Group AG) Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 99. MAG & More GmbH(Neurocare Group AG) Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. MAG & More GmbH(Neurocare Group AG) Main Business
Table 101. MAG & More GmbH(Neurocare Group AG) Latest Developments
Table 102. Shenzhen Yingchi Technology Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. Shenzhen Yingchi Technology Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 104. Shenzhen Yingchi Technology Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Shenzhen Yingchi Technology Main Business
Table 106. Shenzhen Yingchi Technology Latest Developments
Table 107. Sebers Medical Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Sebers Medical Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 109. Sebers Medical Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sebers Medical Main Business
Table 111. Sebers Medical Latest Developments
Table 112. Neurosoft Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. Neurosoft Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 114. Neurosoft Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Neurosoft Main Business
Table 116. Neurosoft Latest Developments
Table 117. Magstim Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. Magstim Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 119. Magstim Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Magstim Main Business
Table 121. Magstim Latest Developments
Table 122. MagVenture Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. MagVenture Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 124. MagVenture Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. MagVenture Main Business
Table 126. MagVenture Latest Developments
Table 127. NeuroStar Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 128. NeuroStar Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 129. NeuroStar Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. NeuroStar Main Business
Table 131. NeuroStar Latest Developments
Table 132. Deymed Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 133. Deymed Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 134. Deymed Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Deymed Main Business
Table 136. Deymed Latest Developments
Table 137. Yiruide Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 138. Yiruide Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 139. Yiruide Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Yiruide Main Business
Table 141. Yiruide Latest Developments
Table 142. Remed Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 143. Remed Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 144. Remed Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Remed Main Business
Table 146. Remed Latest Developments
Table 147. Nexstim Basic Information, Transcranial Magnetic Stimulation Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 148. Nexstim Transcranial Magnetic Stimulation Treatment Devices Product Offered
Table 149. Nexstim Transcranial Magnetic Stimulation Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Nexstim Main Business
Table 151. Nexstim Latest Developments
List of Figures
Figure 1. Picture of Transcranial Magnetic Stimulation Treatment Devices
Figure 2. Transcranial Magnetic Stimulation Treatment Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transcranial Magnetic Stimulation Treatment Devices Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transcranial Magnetic Stimulation Treatment Devices Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Mono-phasic Magnetic Stimulator
Figure 10. Product Picture of Dual-phasic Magnetic Stimulator
Figure 11. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Type in 2021
Figure 12. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Type (2017-2022)
Figure 13. Transcranial Magnetic Stimulation Treatment Devices Consumed in Depression
Figure 14. Global Transcranial Magnetic Stimulation Treatment Devices Market: Depression (2017-2022) & (K Units)
Figure 15. Transcranial Magnetic Stimulation Treatment Devices Consumed in Anxiety Disorder
Figure 16. Global Transcranial Magnetic Stimulation Treatment Devices Market: Anxiety Disorder (2017-2022) & (K Units)
Figure 17. Transcranial Magnetic Stimulation Treatment Devices Consumed in Obsessive-compulsive Disorder
Figure 18. Global Transcranial Magnetic Stimulation Treatment Devices Market: Obsessive-compulsive Disorder (2017-2022) & (K Units)
Figure 19. Transcranial Magnetic Stimulation Treatment Devices Consumed in Smoking Addiction
Figure 20. Global Transcranial Magnetic Stimulation Treatment Devices Market: Smoking Addiction (2017-2022) & (K Units)
Figure 21. Transcranial Magnetic Stimulation Treatment Devices Consumed in Other
Figure 22. Global Transcranial Magnetic Stimulation Treatment Devices Market: Other (2017-2022) & (K Units)
Figure 23. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Application (2017-2022)
Figure 24. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Application in 2021
Figure 25. Transcranial Magnetic Stimulation Treatment Devices Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Company in 2021
Figure 27. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Geographic Region in 2021
Figure 29. Global Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Region (2017-2022)
Figure 30. Global Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country/Region in 2021
Figure 31. Americas Transcranial Magnetic Stimulation Treatment Devices Sales 2017-2022 (K Units)
Figure 32. Americas Transcranial Magnetic Stimulation Treatment Devices Revenue 2017-2022 ($ Millions)
Figure 33. APAC Transcranial Magnetic Stimulation Treatment Devices Sales 2017-2022 (K Units)
Figure 34. APAC Transcranial Magnetic Stimulation Treatment Devices Revenue 2017-2022 ($ Millions)
Figure 35. Europe Transcranial Magnetic Stimulation Treatment Devices Sales 2017-2022 (K Units)
Figure 36. Europe Transcranial Magnetic Stimulation Treatment Devices Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Revenue 2017-2022 ($ Millions)
Figure 39. Americas Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country in 2021
Figure 40. Americas Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country in 2021
Figure 41. United States Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Region in 2021
Figure 46. APAC Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Regions in 2021
Figure 47. China Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country in 2021
Figure 54. Europe Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country in 2021
Figure 55. Germany Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Transcranial Magnetic Stimulation Treatment Devices Revenue Market Share by Country in 2021
Figure 62. Egypt Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Transcranial Magnetic Stimulation Treatment Devices Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Transcranial Magnetic Stimulation Treatment Devices in 2021
Figure 68. Manufacturing Process Analysis of Transcranial Magnetic Stimulation Treatment Devices
Figure 69. Industry Chain Structure of Transcranial Magnetic Stimulation Treatment Devices
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets